Chitosan Nanoparticles in Pulmonary Drug Delivery: Unleashing the Potential for Targeted and Effective Therapy
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71478 ↗At a glance
Übersichtsarbeit in Chemistry & Biodiversity, 2026. Written by Anchal Srivastava and 9 co-authors. Institution: S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva, Gujarat, India. Major MEDLINE topics: Chitosan, Nanoparticles, Lung, Drug Carriers. Cited 1 times so far (Crossref); 59 references.
Abstract (original language)
Pulmonary drug delivery is used for local treatment of lung diseases and for systemic administration of drugs requiring rapid absorption. Drug delivery to the lungs is limited by mucociliary clearance, macrophage uptake, and short residence time of inhaled formulations. Polymer‐based carrier systems have therefore been explored to improve lung retention and delivery efficiency. Chitosan, a polysaccharide obtained from chitin, is biodegradable, biocompatible, and positively charged, enabling interaction with negatively charged pulmonary mucus. When formulated as nanoparticles, chitosan allows modulation of particle size, surface charge, and drug release behavior, which are critical parameters for pulmonary deposition. Chitosan nanoparticles have been investigated for delivery of small molecules, proteins, and nucleic acids in respiratory infections, inflammatory lung diseases, and lung cancer. Reported studies demonstrate improved lung localization and sustained drug release compared with conventional formulations. This review summarizes formulation approaches used for the preparation of chitosan nanoparticles for pulmonary delivery and discusses key physicochemical factors influencing their performance. Limitations related to aerosolization behavior and formulation reproducibility are also considered.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva, Gujarat, India.
- Department of Pharmaceutics, Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Vadodara, Gujarat, India.
- Deparment of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gujarat, India.
- Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas, USA.
- School of Pharmacy, RK University, Rajkot, Gujarat, India.
- Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia.
ORCID profiles: Bhupendra G Prajapati, Sagar Salave, Kiran Dudhat, Omar Awad Alsaidan, Sami I Alzarea, Dignesh Khunt, Chandrakantsing V Pardeshi, Namdev Dhas
Cite
APA
Srivastava, A., Prajapati, B. G., Salave, S., Dudhat, K., Alsaidan, O. A., Alzarea, S. I., Khunt, D., Pardeshi, C. V., Dhas, N., & Patel, S. (2026). Chitosan Nanoparticles in Pulmonary Drug Delivery: Unleashing the Potential for Targeted and Effective Therapy. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71478
Vancouver
Srivastava A, Prajapati BG, Salave S, Dudhat K, Alsaidan OA, Alzarea SI, et al. Chitosan Nanoparticles in Pulmonary Drug Delivery: Unleashing the Potential for Targeted and Effective Therapy. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71478
BibTeX
@article{Srivastava2026,
author = {Srivastava, Anchal and Prajapati, Bhupendra G and Salave, Sagar and Dudhat, Kiran and Alsaidan, Omar Awad and Alzarea, Sami I and Khunt, Dignesh and Pardeshi, Chandrakantsing V and Dhas, Namdev and Patel, Suhaskumar},
title = {Chitosan Nanoparticles in Pulmonary Drug Delivery: Unleashing the Potential for Targeted and Effective Therapy},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71478}
}
EUVIMED